Email updates

Keep up to date with the latest news and content from BMC Pharmacology and BioMed Central.

This article is part of the supplement: 2nd International Conference of cGMP Generators, Effectors and Therapeutic Implications

Open Access Oral presentation

Exploring vasomotor mechanisms using PKG specific inhibitors

Wolfgang Dostmann

Author Affiliations

University of Vermont, College of Medicine, Department of Pharmacology, Burlington, Vermont, USA

BMC Pharmacology 2005, 5(Suppl 1):S15  doi:10.1186/1471-2210-5-S1-S15


The electronic version of this article is the complete one and can be found online at:


Published:16 June 2005

©

Oral presentation

The regulation of vascular tone is fundamentally linked to the activity of cGMP-dependent protein kinase (PKG). cGMP-induced activation of PKG presents a key step in the nitric oxide (NO) mediated reduction of intracellular Ca2+ and ultimately in vascular smooth muscle (VSM) relaxation. 'Acute' PKG inhibition in the vasculature by the use of our recently developed potent and membrane-permeable PKG inhibitors, point to a novel, cGMP-independent role for PKG in smooth muscle. First, work done using DT-2 and the proteolytically stable analog (D)DT-2 suggests that constitutive PKG activity may play a functional role in the control of vascular tone. A second key discovery implies that the expression of PKG in small resistance arteries is dependent on intraluminal pressure. Virtually nothing is known about the role of basal PKG activity as well as the mechano-sensitive expression of PKG in the control of VSM relaxation. Both findings suggest a new concept, whereby PKG may play a role in modulating vascular tone autonomous of cGMP.